The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Eluting Balloons (DEB) Market Research Report 2025
Synopsis
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
The global Drug Eluting Balloons (DEB) market was valued at US$ 584 million in 2023 and is anticipated to reach US$ 1396.1 million by 2030, witnessing a CAGR of 13.1% during the forecast period 2024-2030.
Global Drug Eluting Balloons（DEB） key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloons (DEB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloons (DEB).
Report Scope
The Drug Eluting Balloons (DEB) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloons (DEB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Segment by Type
Peripheral DEBs
Coronary DEBs
Segment by Application
Catheterization Laboratory
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
The global Drug Eluting Balloons (DEB) market was valued at US$ 584 million in 2023 and is anticipated to reach US$ 1396.1 million by 2030, witnessing a CAGR of 13.1% during the forecast period 2024-2030.
Global Drug Eluting Balloons（DEB） key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloons (DEB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloons (DEB).
Report Scope
The Drug Eluting Balloons (DEB) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloons (DEB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Segment by Type
Peripheral DEBs
Coronary DEBs
Segment by Application
Catheterization Laboratory
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drug Eluting Balloons (DEB) Market Overview
1.1 Product Overview and Scope of Drug Eluting Balloons (DEB)
1.2 Drug Eluting Balloons (DEB) Segment by Type
1.2.1 Global Drug Eluting Balloons (DEB) Market Value Comparison by Type (2024-2030)
1.2.2 Peripheral DEBs
1.2.3 Coronary DEBs
1.3 Drug Eluting Balloons (DEB) Segment by Application
1.3.1 Global Drug Eluting Balloons (DEB) Market Value by Application: (2024-2030)
1.3.2 Catheterization Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global Drug Eluting Balloons (DEB) Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Balloons (DEB) Revenue 2019-2030
1.4.2 Global Drug Eluting Balloons (DEB) Sales 2019-2030
1.4.3 Global Drug Eluting Balloons (DEB) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Balloons (DEB) Market Competition by Manufacturers
2.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Balloons (DEB) Average Price by Manufacturers (2019-2024)
2.4 Global Drug Eluting Balloons (DEB) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
2.7 Drug Eluting Balloons (DEB) Market Competitive Situation and Trends
2.7.1 Drug Eluting Balloons (DEB) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Balloons (DEB) Players Market Share by Revenue
2.7.3 Global Drug Eluting Balloons (DEB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Balloons (DEB) Retrospective Market Scenario by Region
3.1 Global Drug Eluting Balloons (DEB) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Balloons (DEB) Global Drug Eluting Balloons (DEB) Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Balloons (DEB) Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Balloons (DEB) Sales by Region: 2025-2030
3.3 Global Drug Eluting Balloons (DEB) Global Drug Eluting Balloons (DEB) Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Balloons (DEB) Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Balloons (DEB) Revenue by Region: 2025-2030
3.4 North America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloons (DEB) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Balloons (DEB) Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Balloons (DEB) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloons (DEB) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Balloons (DEB) Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Balloons (DEB) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Balloons (DEB) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloons (DEB) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Balloons (DEB) Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Balloons (DEB) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloons (DEB) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Balloons (DEB) Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Balloons (DEB) Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Balloons (DEB) Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Balloons (DEB) Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Balloons (DEB) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Balloons (DEB) Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Balloons (DEB) Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Balloons (DEB) Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Balloons (DEB) Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Balloons (DEB) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Drug Eluting Balloons (DEB) Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Drug Eluting Balloons (DEB) Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Drug Eluting Balloons (DEB) Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Yinyi
6.5.1 Yinyi Corporation Information
6.5.2 Yinyi Description and Business Overview
6.5.3 Yinyi Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yinyi Drug Eluting Balloons (DEB) Product Portfolio
6.5.5 Yinyi Recent Developments/Updates
6.6 Philips
6.6.1 Philips Corporation Information
6.6.2 Philips Description and Business Overview
6.6.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Philips Drug Eluting Balloons (DEB) Product Portfolio
6.6.5 Philips Recent Developments/Updates
6.7 Eurocor
6.6.1 Eurocor Corporation Information
6.6.2 Eurocor Description and Business Overview
6.6.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eurocor Drug Eluting Balloons (DEB) Product Portfolio
6.7.5 Eurocor Recent Developments/Updates
6.8 Aachen Resonance
6.8.1 Aachen Resonance Corporation Information
6.8.2 Aachen Resonance Description and Business Overview
6.8.3 Aachen Resonance Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aachen Resonance Drug Eluting Balloons (DEB) Product Portfolio
6.8.5 Aachen Resonance Recent Developments/Updates
6.9 Biotronic
6.9.1 Biotronic Corporation Information
6.9.2 Biotronic Description and Business Overview
6.9.3 Biotronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biotronic Drug Eluting Balloons (DEB) Product Portfolio
6.9.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloons (DEB) Industry Chain Analysis
7.2 Drug Eluting Balloons (DEB) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloons (DEB) Production Mode & Process
7.4 Drug Eluting Balloons (DEB) Sales and Marketing
7.4.1 Drug Eluting Balloons (DEB) Sales Channels
7.4.2 Drug Eluting Balloons (DEB) Distributors
7.5 Drug Eluting Balloons (DEB) Customers
8 Drug Eluting Balloons (DEB) Market Dynamics
8.1 Drug Eluting Balloons (DEB) Industry Trends
8.2 Drug Eluting Balloons (DEB) Market Drivers
8.3 Drug Eluting Balloons (DEB) Market Challenges
8.4 Drug Eluting Balloons (DEB) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
